- Details
- Description
Daprostat (Daprodustat INN 4 mg) is a pharmaceutical product manufactured by Everest Pharmaceuticals Ltd. and contains daprodustat 4 mg. Daprodustat belongs to the HIF-prolyl hydroxylase inhibitor (HIF-PHI) class and is used in the management of anemia associated with chronic kidney disease (CKD) in appropriate adult patients, including patients receiving dialysis. By inhibiting HIF-prolyl hydroxylase enzymes, daprodustat helps activate the body's natural response to reduced oxygen availability and supports the production of red blood cells. Daprostat 4 mg is available in tablet form and is intended for use under appropriate medical supervision. It is primarily associated with nephrology and the management of CKD-related anemia.
